A detailed history of Ghost Tree Capital, LLC transactions in Intra Cellular Therapies, Inc. stock. As of the latest transaction made, Ghost Tree Capital, LLC holds 10,000 shares of ITCI stock, worth $854,700. This represents 0.28% of its overall portfolio holdings.

Number of Shares
10,000
Previous 50,000 80.0%
Holding current value
$854,700
Previous $3.46 Million 80.23%
% of portfolio
0.28%
Previous 1.12%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$64.76 - $79.84 $647,600 - $798,400
10,000 New
10,000 $684,000
Q3 2022

Nov 14, 2022

BUY
$42.7 - $59.99 $2.56 Million - $3.6 Million
60,000 New
60,000 $2.79 Million

Others Institutions Holding ITCI

About Intra-Cellular Therapies, Inc.


  • Ticker ITCI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 94,401,696
  • Market Cap $8.07B
  • Description
  • Intra-Cellular Therapies, Inc., a biopharmaceutical company, develops novel drugs for the treatment of neuropsychiatric and neurologic diseases by targeting intracellular signaling mechanisms within the central nervous system in the United States. The company offers CAPLYTA for the treatment of schizophrenia in adults. It is also involved in dev...
More about ITCI
Track This Portfolio

Track Ghost Tree Capital, LLC Portfolio

Follow Ghost Tree Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ghost Tree Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ghost Tree Capital, LLC with notifications on news.